Multisystemic functions of alkaline phosphatases

Methods in Molecular Biology

Volumn 1053, Issue , 2013, Pages 27-51

  Buchet, René ^a   Millán, José Luis ^b   Magne, David ^a  

^a UNIVERSITÉ LYON 1   (France)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Detoxification; Epilepsy; IAP; Inflammation; LPS; Mineralization; TNAP; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; CD36 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BRUSH BORDER; CONTROLLED STUDY; CPG ISLAND; ENZYME PHOSPHORYLATION; FATTY LIVER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; LIPID DIET; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; UPREGULATION;

ALKALINE PHOSPHATASE; ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD36; ENZYME REPLACEMENT THERAPY; FATTY ACIDS; GPI-LINKED PROTEINS; HUMANS; HYPOPHOSPHATASIA; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; UP-REGULATION;

EID: 84881087204     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-562-0_3     Document Type: Article

References (155)

1. Millan JL (2006) Mammalian alkaline phosphatases: From biology to applications in medicine and biotechnology. Wiley-VCH, Weinheim
2. Weiss MJ, Ray K, Henthorn PS et al (1988) Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263:12002-12010
3. Kishi F, Matsuura S, Kajii T (1989) Nucleotide sequence of the human liver-Type alkaline phosphatase cDNA. Nucleic Acids Res 17:2129
4. Matsuura S, Kishi F, Kajii T (1990) Characterization of a 5'-fl anking region of the human liver/bone/kidney alkaline phosphatase gene: Two kinds of mRNA from a single gene. Biochem Biophys Res Commun 168:993-1000
5. Studer M, Terao M, Gianni M et al (1991) Characterization of a second promoter for the mouse liver/bone/kidney-Type alkaline phosphatase gene: Cell and tissue specifi c expression. Biochem Biophys Res Commun 179:1352-1360
6. Martin D, Tucker DF, Gorman P et al (1987) The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Genet 51: 145-152
7. Griffi n CA, Smith M, Henthorn PS et al (1987) Human placental and intestinal alkaline phosphatase genes map to 2q34-q37. Am J Hum Genet 41:1025-1034
8. Henthorn PS, Raducha M, Edwards YH et al (1987) Nucleotide and amino acid sequences of human intestinal alkaline phosphatase: Close homology to placental alkaline phosphatase. Proc Natl Acad Sci U S A 84:1234-1238
9. Knoll BJ, Rothblum KN, Longley M (1988) Nucleotide sequence of the human placental alkaline phosphatase gene. Evolution of the 5' fl anking region by deletion/substitution. J Biol Chem 263:12020-12027
10. Millán JL, Manes T (1988) Seminomaderived Nagao isozyme is encoded by a germcell alkaline phosphatase gene. Proc Natl Acad Sci U S A 85:3024-3028
11. Ovitt CE, Strauss AW, Alpers DH et al (1986) Expression of different-sized placental alkaline phosphatase mRNAs in placenta and choriocarcinoma cells. Proc Natl Acad Sci U S A 83:3781-3785
12. Gum JR, Kam WK, Byrd JC et al (1987) Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placentallike alkaline phosphatase. J Biol Chem 262:1092-1097
13. Chou JY, Takahashi S (1987) Control of placental alkaline phosphatase gene expression in HeLa cells: Induction of synthesis by prednisolone and sodium butyrate. Biochemistry 26:3596-3602
14. Terao M, Pravtcheva D, Ruddle FH et al (1988) Mapping of gene encoding mouse placental alkaline phosphatase to chromosome 4. Somat Cell Mol Genet 14:211-215
15. Manes T, Glade K, Ziomek CA et al (1990) Genomic structure and comparison of mouse tissue-specifi c alkaline phosphatase genes. Genomics 8:541-554
16. Narisawa S, Hoylaerts MF, Doctor KS et al (2007) A novel phosphatase upregulated in Akp3 knockout mice. Am J Physiol Gastrointest Liver Physiol 293:G1068-G1077
17. Merchant-Larios H, Mendlovic F, Alvarez-Buylla A (1985) Characterization of alkaline phosphatase from primordial germ cells and ontogenesis of this enzyme in the mouse. Differentiation 29:145-151
18. MacGregor GR, Zambrowicz BP, Soriano P (1995) Tissue non-specifi c alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Development 121:1487-1496
19. Narisawa S, Hasegawa H, Watanabe K et al (1994) Stage-specifi c expression of alkaline phosphatase during neural development in the mouse. Dev Dyn 201:227-235
20. Hoshi K, Amizuka N, Oda K et al (1997) Immunolocalization of tissue non-specifi c alkaline phosphatase in mice. Histochem Cell Biol 107:183-191
21. Fonta C, Négyessy L, Renaud L et al (2004) Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: Evidence for a role in neurotransmission. Cereb Cortex 14:595-609
22. Langer D, Hammer K, Koszalka P et al (2008) Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res 334:199-217
23. Brun-Heath I, Ermonval M, Chabrol E et al (2011) Differential expression of the bone and the liver tissue non-specifi c alkaline phosphatase isoforms in brain tissues. Cell Tissue Res 343:521-536
24. Négyessy L, Xiao J, Kántor O et al (2011) Layer-specifi c activity of tissue non-specifi c alkaline phosphatase in the human neocortex. Neuroscience 172:406-418
25. Hahnel AC, Rappolee DA, Millan JL et al (1990) Two alkaline phosphatase genes are expressed during early development in the mouse embryo. Development 110:555-564
26. Hustin J, Collette J, Franchimont P (1987) Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 10:29-35
27. Chang CH, Angellis D, Fishman WH (1980) Presence of the rare D-variant heat-stable, placental-Type alkaline phosphatase in normal human testis. Cancer Res 40:1506-1510
28. Goldstein DJ, Rogers C, Harris H (1982) A search for trace expression of placental-like alkaline phosphatase in non-malignant human tissues: Demonstration of its occurrence in lung, cervix, testis and thymus. Clin Chim Acta 125:63-75
29. Fishman L, Miyayama H, Driscoll SG et al (1976) Developmental phase-specifi c alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res 36:2268-2273
30. Jemmerson R, Klier FG, Fishman WH (1985) Clustered distribution of human placental alkaline phosphatase on the surface of both placental and cancer cells. Electron microscopic observations using gold-labeled antibodies. J Histochem Cytochem 33:1227-1234
31. Kozlenkov A, Manes T, Hoylaerts MF et al (2002) Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem 277:22992-22999
32. Kozlenkov A, Le Du MH, Cuniasse P et al (2004) Residues determining the binding specifi city of uncompetitive inhibitors to tissue-nonspecifi c alkaline phosphatase. J Bone Miner Res 19:1862-1872
33. Le Du MH, Millan JL (2002) Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 277:49808-49814
34. Hoylaerts MF, Manes T, Millán JL (1997) Mammalian alkaline phosphatases are allosteric enzymes. J Biol Chem 272:22781-22787
35. Hoylaerts MF, Ding L, Narisawa S et al (2006) Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-Terminal amino acid microenvironment. Biochemistry 45:9756-9766
36. Bossi M, Hoylaerts MF, Millán JL (1993) Modifi cations in a fl exible surface loop modulate the isozyme-specifi c properties of mammalian alkaline phosphatases. J Biol Chem 268:25409-25416
37. Halling LC, Narisawa S, Millán JL et al (2009) Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 45:987-993
38. Zhang L, Balcerzak M, Radisson J et al (2005) Phosphodiesterase activity of alkaline phosphatase in ATP-initiated Ca 2+ and phosphate deposition in isolated chicken matrix vesicles. J Biol Chem 280:37289-37296
39. Morris DC, Masuhara K, Takaoka K et al (1992) Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Miner 19:287-298
40. Hawrylak K, Stinson RA (1988) The solubilization of tetrameric alkaline phosphatase from human liver and its conversion into various forms by phosphatidylinositol phospholipase C or proteolysis. J Biol Chem 263:14368-14373
41. Anh DJ, Eden A, Farley JR (2001) Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum. Clin Chim Acta 311:137-148
42. Low MG, Prasad AR (1988) A phospholipase D specifi c for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci U S A 85:980-984
43. Davitz MA, Hereld D, Shak S et al (1987) A glycan-phosphatidylinositol- specifi c phospholipase D in human serum. Science 238:81-84
44. Magnusson P, Degerblad M, Sääf M et al (1997) Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone defi ciency. J Bone Miner Res 12:210-220
45. Smith GP, Peters TJ (1981) Subcellular localization and properties of pyridoxal phosphate phosphatases of human polymorphonuclear leukocytes and their relationship to acid and alkaline phosphatase. Biochim Biophys Acta 661:287-294
46. Wilson PD, Smith GP, Peters TJ (1983) Pyridoxal 5'-phosphate: A possible physiological substrate for alkaline phosphatase in human neutrophils. Histochem J 15:257-264
47. Low MG, Saltiel AR (1988) Structural and functional roles of glycosyl-phosphatidylinositol in membranes. Science 239:268-275
48. Waymire KG, Mahuren JD, Jaje JM et al (1995) Mice lacking tissue non-specifi c alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45-51
49. Fleshood HL, Pitot HC (1970) The metabolism of O-phosphorylethanolamine in animal tissues. I. O-phosphorylethanolamine phospho-lyase: Partial purifi cation and characterization. J Biol Chem 245:4414-4420
50. Lencel P, Delplace S, Pilet P et al (2011) Cellspecifi c effects of TNF-A and IL-1ß on alkaline phosphatase: Implication for syndesmophyte formation and vascular calcifi-cation. Lab Invest 91:1434-1442
51. Krause U, Harris S, Green A et al (2010) Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci U S A 107:4147-4152
52. Briolay A, Lencel P, Bessueille L et al (2013) Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-A in human mesenchymal stem cells. Biochem Biophys Res Commun 430:1072-1077
53. Delgado-Calle J, Sañudo C, Sánchez-Verde L et al (2011) Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone 49:830-838
54. Bernard GW (1978) Ultrastructural localization of alkaline phosphatase in initial intramembranous osteogenesis. Clin Orthop Relat Res 218-225
55. Togari A, Arakawa S, Arai M et al (1993) Inhibition of in vitro mineralization in osteoblastic cells and in mouse tooth germ by phosphatidylinositol-specifi c phospholipase C. Biochem Pharmacol 46:1668-1670
56. Hsu HH, Morris DC, Davis L et al (1993) In vitro Ca deposition by rat matrix vesicles: Is the membrane association of alkaline phosphatase essential for matrix vesicle-mediated calcium deposition? Int J Biochem 25:1737-1742
57. Sugawara Y, Suzuki K, Koshikawa M et al (2002) Necessity of enzymatic activity of alkaline phosphatase for mineralization of osteoblastic cells. Jpn J Pharmacol 88:262-269
58. Whyte MP, Valdes R, Ryan LM et al (1982) Infantile hypophosphatasia: Enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. J Pediatr 101:379-386
59. Whyte MP, McAlister WH, Patton LS et al (1984) Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphataserich Paget plasma: Results in three additional patients. J Pediatr 105:926-933
60. Weninger M, Stinson RA, Plenk H et al (1989) Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia. Acta Paediatr Scand Suppl 360:154-160
61. Millán JL, Narisawa S, Lemire I et al (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777-787
62. Whyte MP, Greenberg CR, Salman NJ et al (2012) Enzyme-replacement therapy in lifethreatening hypophosphatasia. N Engl J Med 366:904-913
63. Krawitz PM, Schweiger MR, Rödelsperger C et al (2010) Identity-by-descent fi ltering of exome sequence data identifi es PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 42:827-829
64. Weiss MJ, Cole DE, Ray K et al (1988) A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85:7666-7669
65. Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 1192:190-200
66. Fallon MD, Teitelbaum SL, Weinstein RS et al (1984) Hypophosphatasia: Clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 63:12-24
67. Anderson HC, Hsu HH, Morris DC et al (1997) Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555-1561
68. Yadav MC, Simão AM, Narisawa S et al (2011) Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: A unifi ed model of the mechanisms of initiation of skeletal calcifi cation. J Bone Miner Res 26:286-297
69. Millán JL (2012) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int (10.1007/s00223-012-9672-8
70. Fedde KN, Blair L, Silverstein J et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015-2026
71. Zalatan JG, Fenn TD, Brunger AT et al (2006) Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: Implications for mechanism and evolution. Biochemistry 45:9788-9803
72. Ciancaglini P, Yadav MC, Simão AM et al (2010) Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-defi cient matrix vesicles. J Bone Miner Res 25:716-723
73. Murshed M, Harmey D, Millán JL et al (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093-1104
74. Fernley HN, Walker PG (1967) Studies on alkaline phosphatase. Inhibition by phosphate derivatives and the substrate specifi city. Biochem J 104:1011-1018
75. Hessle L, Johnson KA, Anderson HC et al (2002) Tissue-nonspecifi c alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 99:9445-9449
76. Harmey D, Hessle L, Narisawa S et al (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199-1209
77. Thouverey C, Bechkoff G, Pikula S et al (2009) Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles. Osteoarthritis Cartilage 17:64-72
78. Foster B, Nagatomo K, Tso H et al (2013) Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res 28:271-282
79. Foster BL, Nagatomo KJ, Nociti FH et al (2012) Central role of pyrophosphate in acellular cementum formation. PLoS One 7:e38393
80. McKee MD, Nakano Y, Masica DL et al (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90:470-476
81. Yadav MC, de Oliveira RC, Foster BL et al (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27:1722-1734
82. Tesch W, Vandenbos T, Roschgr P et al (2003) Orientation of mineral crystallites and mineral density during skeletal development in mice defi cient in tissue nonspecifi c alkaline phosphatase. J Bone Miner Res 18:117-125
83. Thompson MD, Killoran A, Percy ME et al (2006) Hyperphosphatasia with neurologic defi cit: A pyridoxine-responsive seizure disorder? Pediatr Neurol 34:303-307
84. Gospe SM (2006) Pyridoxine-dependent seizures: New genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 19:148-153
85. Narisawa S, Fröhlander N, Millán JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432-446
86. Narisawa S, Wennberg C, Millán JL (2001) Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol 193:125-133
87. Baumgartner-Sigl S, Haberlandt E, Mumm S et al (2007) Pyridoxine-responsive seizures as the fi rst symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecifi c alkaline phosphatase gene. Bone 40:1655-1661
88. Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40
89. Hanics J, Barna J, Xiao J et al (2012) Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain. Cell Tissue Res 349(2):459-471
90. Kermer V, Ritter M, Albuquerque B et al (2010) Knockdown of tissue nonspecifi c alkaline phosphatase impairs neural stem cell proliferation and differentiation. Neurosci Lett 485:208-211
91. Díez-Zaera M, Díaz-Hernández JI, Hernández-Álvarez E et al (2011) Tissuenonspecifi c alkaline phosphatase promotes axonal growth of hippocampal neurons. Mol Biol Cell 22:1014-1024
92. Ermonval M, Baudry A, Baychelier F et al (2009) The cellular prion protein interacts with the tissue non-specifi c alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells. PLoS One 4:e6497
93. Hatoff DE, Hardison WG (1981) Bile acids modify alkaline phosphatase induction and bile secretion pressure after bile duct obstruction in the rat. Gastroenterology 80: 666-672
94. Hatoff DE, Hardison WG (1982) Bile aciddependent secretion of alkaline phosphatase in rat bile. Hepatology 2:433-439
95. Chida K, Taguchi M (2005) Localization of alkaline phosphatase and proteins related to intercellular junctions in primary cultures of fetal rat hepatocytes. Anat Embryol (Berl) 210:75-80
96. Chida K, Taguchi M (2011) Localization of alkaline phosphatase and cathepsin D during cell restoration after colchicine treatment in primary cultures of fetal rat hepatocytes. Acta Histochem Cytochem 44:155-158
97. Ogawa H, Mink J, Hardison WG et al (1990) Alkaline phosphatase activity in hepatic tissue and serum correlates with amount and type of bile acid load. Lab Invest 62:87-95
98. Halling Linder C, Englund UH, Narisawa S et al (2013) Isozyme profi le and tissue-origin of alkaline phosphatases in mouse serum. Bone 53(2):399-408
99. Kaplan MM, Righetti A (1970) Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J Clin Invest 49:508-516
100. Poelstra K, Bakker WW, Klok PA et al (1997) A physiologic function for alkaline phosphatase: Endotoxin detoxifi cation. Lab Invest 76:319-327
101. Alvaro D, Benedetti A, Marucci L et al (2000) The function of alkaline phosphatase in the liver: Regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology 32:174-184
102. Becq F, Jensen TJ, Chang XB et al (1994) Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A 91:9160-9164
103. Becq F, Fanjul M, Merten M et al (1993) Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells. FEBS Lett 327:337-342
104. Hori Y, Takeyama Y, Ueda T et al (1998) Impaired transport of lipopolysaccharide across the hepatocytes in rats with ceruleininduced experimental pancreatitis. Pancreas 16:148-153
105. Kanistanon D, Powell DA, Hajjar AM et al (2012) Role of Francisella lipid A phosphate modifi cation in virulence and long-Term protective immune responses. Infect Immun 80:943-951
106. Rietschel ET, Kirikae T, Schade FU et al (1994) Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J 8:217-225
107. Bentala H, Verweij WR, Huizinga-Van der Vlag A et al (2002) Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18:561-566
108. Tuin A, Huizinga-Van der Vlag A, van Loenen-Weemaes AM et al (2006) On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 290:G377-G385
109. Poelstra K, Bakker WW, Klok PA et al (1997) Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol 151:1163-1169
110. Nouwen EJ, De Broe ME (1994) Human intestinal versus tissue-nonspecifi c alkaline phosphatase as complementary urinary markers for the proximal tubule. Kidney Int Suppl 47:S43-S51
111. March JG, Simonet BM, Grases F (2001) Determination of pyrophosphate in renal calculi and urine by means of an enzymatic method. Clin Chim Acta 314:187-194
112. Baumann JM, Bisaz S, Felix R et al (1977) The role of inhibitors and other factors in the pathogenesis of recurrent calcium-containing renal stones. Clin Sci Mol Med 53:141-148
113. Laminski NA, Meyers AM, Sonnekus MI et al (1990) Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: As isolated defects or associated with other metabolic abnormalities. Nephron 56:379-386
114. Goldberg RF, Austen WG, Zhang X et al (2008) Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A 105:3551-3556
115. Russell RG, Bisaz S, Fleisch H (1976) The infl uence of orthophosphate on the renal handling of inorganic pyrophosphate in man and dog. Clin Sci Mol Med 51:435-443
116. Rachow JW, Ryan LM (1988) Inorganic pyrophosphate metabolism in arthritis. Rheum Dis Clin North Am 14:289-302
117. Moochhala SH, Sayer JA, Carr G et al (2008) Renal calcium stones: Insights from the control of bone mineralization. Exp Physiol 93:43-49
118. Ho AM, Johnson MD, Kingsley DM (2000) Role of the mouse ank gene in control of tissue calcifi cation and arthritis. Science 289:265-270
119. Carr G, Sayer JA, Simmons NL (2007) Expression and localisation of the pyrophosphate transporter, ANK, in murine kidney cells. Cell Physiol Biochem 20:507-516
120. Kapojos JJ, Poelstra K, Borghuis T et al (2003) Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide. Int J Exp Pathol 84:135-144
121. Lencel P, Magne D (2011) Infl ammaging: The driving force in osteoporosis? Med Hypotheses 76:317-321
122. Lencel P, Hardouin P, Magne D (2010) Do cytokines induce vascular calcifi cation by the mere stimulation of TNAP activity? Med Hypotheses 75:517-521
123. Doherty TM, Fitzpatrick LA, Inoue D et al (2004) Molecular, endocrine, and genetic mechanisms of arterial calcifi cation. Endocr Rev 25:629-672
124. Mintz GS, Popma JJ, Pichard AD et al (1995) Patterns of calcifi cation in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 91:1959-1965
125. Vengrenyuk Y, Carlier S, Xanthos S et al (2006) A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifi cations in thin fi brous caps. Proc Natl Acad Sci U S A 103:14678-14683
126. Tyson KL, Reynolds JL, McNair R et al (2003) Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcifi cation. Arterioscler Thromb Vasc Biol 23:489-494
127. Ishimura E, Okuno S, Kitatani K et al (2002) Different risk factors for peripheral vascular calcifi cation between diabetic and non-diabetic haemodialysis patients-importance of glycaemic control. Diabetologia 45:1446-1448
128. Shanahan CM, Cary NR, Salisbury JR et al (1999) Medial localization of mineralizationregulating proteins in association with Mönckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcifi cation. Circulation 100:2168-2176
129. Lomashvili KA, Garg P, Narisawa S et al (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcifi cation. Kidney Int 73:1024-1030
130. Narisawa S, Harmey D, Yadav MC et al (2007) Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcifi cation. J Bone Miner Res 22:1700-1710
131. Markello TC, Pak LK, St HC et al (2011) Vascular pathology of medial arterial calcifi cations in NT5E defi ciency: Implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab 103:44-50
132. Munroe PB, Olgunturk RO, Fryns JP et al (1999) Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142-144
133. Lomashvili KA, Wang X, Wallin R et al (2011) Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcifi cation. J Biol Chem 286:28715-28722
134. Leroux-Berger M, Queguiner I, Maciel TT et al (2011) Pathologic calcifi cation of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin. J Bone Miner Res 26:1543-1553
135. Li L, Chang L, Pellet-Rostaing S et al (2009) Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases. Bioorg Med Chem 17:7290-7300
136. Dahl R, Sergienko EA, Su Y et al (2009) Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissuenonspecifi c alkaline phosphatase (TNAP). J Med Chem 52:6919-6925
137. Li JJ, Zhu CG, Yu B et al (2007) The role of infl ammation in coronary artery calcifi cation. Ageing Res Rev 6:263-270
138. Stompór T, Pasowicz M, Sullowicz W et al (2003) An association between coronary artery calcifi cation score, lipid profi le, and selected markers of chronic infl ammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203-211
139. Aikawa E, Nahrendorf M, Figueiredo JL et al (2007) Osteogenesis associates with infl ammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116:2841-2850
140. Al-Aly Z, Shao JS, Lai CF et al (2007) Aortic Msx2-Wnt calcifi cation cascade is regulated by TNF-Alpha-dependent signals in diabetic Ldlr-/-mice. Arterioscler Thromb Vasc Biol 27:2589-2596
141. Tintut Y, Patel J, Parhami F et al (2000) Tumor necrosis factor-Alpha promotes in vitro calcifi cation of vascular cells via the cAMP pathway. Circulation 102:2636-2642
142. Tintut Y, Patel J, Territo M et al (2002) Monocyte/macrophage regulation of vascular calcifi cation in vitro. Circulation 105:650-655
143. Doherty TM, Asotra K, Fitzpatrick LA et al (2003) Calcifi cation in atherosclerosis: Bone biology and chronic infl ammation at the arterial crossroads. Proc Natl Acad Sci U S A 100:11201-11206
144. Iqbal K, Wang X, Blanchard J et al (2010) Alzheimer's disease neurofi brillary degeneration: Pivotal and multifactorial. Biochem Soc Trans 38:962-966
145. Díaz-Hernández M, Gómez-Ramos A, Rubio A et al (2010) Tissue-nonspecifi c alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem 285:32539-32548
146. Vardy ER, Kellett KA, Cocklin SL et al (2012) Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease. Neurodegener Dis 9:31-37
147. Glickman RM, Alpers DH, Drummey GD et al (1970) Increased lymph alkaline phosphatase after fat feeding: Effects of medium chain triglycerides and inhibition of protein synthesis. Biochim Biophys Acta 201:226-235
148. Hodin RA, Graham JR, Meng S et al (1994) Temporal pattern of rat small intestinal gene expression with refeeding. Am J Physiol 266:G83-G89
149. Narisawa S, Huang L, Iwasaki A et al (2003) Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 23:7525-7530
150. Nakano T, Inoue I, Koyama I et al (2007) Disruption of the murine intestinal alkaline phosphatase gene Akp3 impairs lipid transcytosis and induces visceral fat accumulation and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 292:G1439-G1449
151. Pool C, Nutting DF, Simmonds WJ et al (1991) Effect of Pluronic L81, a hydrophobic surfactant, on intestinal mucosal cholesterol homeostasis. Am J Physiol 261:G256-G262
152. Mahmood A, Yamagishi F, Eliakim R et al (1994) A possible role for rat intestinal surfactant-like particles in transepithelial triacylglycerol transport. J Clin Invest 93:70-80
153. Lynes M, Narisawa S, Millán JL et al (2011) Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet. Am J Physiol Regul Integr Comp Physiol 301:R1738-R1747
154. Malo MS, Alam SN, Mostafa G et al (2010) Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59:1476-1484
155. Ramasamy S, Nguyen DD, Eston MA et al (2011) Intestinal alkaline phosphatase has benefi cial effects in mouse models of chronic colitis. Infl amm Bowel Dis 17:532-542